Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case –control study

ConclusionsIn this first investigation of folic acid supplement use and breast cancer risk inBRCA mutation carriers, these findings suggest that moderate folic acid- and vitamin B12-containing supplement use may be protective forBRCA-associated breast cancer, particularly amongBRCA1 mutation carriers. Future studies with larger samples and prospective follow-up are needed.

http://link.springer.com/10.1007/s10549-018-05118-3

Source: Breast Cancer Research and Treatment - January 2, 2019 Category: Cancer & Oncology Source Type: research